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Purpose. Inﬁltrative microscopical peripheral growth of soft tissue sarcomas (STS) has been shown to be of prognostic impor-
tance and preoperative risk stratiﬁcation could individualize neoadjuvant treatment. Patients and methods. We assessed peripheral
tumour growth pattern on preoperative MRI from 78 STS. The ﬁndings were correlated to histopathology and to outcome. Re-
sults. The MRI-based peripheral tumour growth pattern was classiﬁed as pushing in 34 tumours, focally inﬁltrative in 25, and
diﬀusely inﬁltrative in 19. All tumours with diﬀuse inﬁltration on MRI also showed microscopical inﬁltration, whereas MRI failed
to identify inﬁltration in two-thirds of the microscopically inﬁltrative tumours. Diﬀusely inﬁltrative growth on MRI gave a 2.5
times increased risk of metastases (P = .01) and a 3.7 times higher risk of local recurrence (P = .02). Discussion. Based on this
observation we suggest that MRI evaluation of STS should focus on the peripheral tumour growth pattern since it adds prognostic
information of value for decisions on neoadjuvant therapies.
Copyright © 2006 Joseﬁn Fernebro et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Soft tissue sarcomas (STS) are rare and heterogenous tu-
mours that often require combination therapy. Despite mul-
tidisciplinary and multimodality treatment, 10–20% of the
tumours recur locally and distant metastases develop in
about 30% of the patients [1, 2]. Various prognostic sys-
tems are in use, most of which are based on combinations
of tumour size, histologic malignancy grade, necrosis, and
vascular invasion [1, 3, 4]. Tumour size can be determined
by preoperative imaging, whereas preoperative assessment of
theotherfactorswillbebased onthelimited biopsy material.
MRIistheimaging modality thatismostfrequentlyusednot
only for preoperative evaluation of tumour size but also for
the mapping of the anatomical extension of STS [5–7]. Prog-
nostic factors that can be evaluated preoperatively would be
clinically valuable in order to identify high-risk patients for
neoadjuvant radiotherapy and chemotherapy.
We have recently shown that STS with a microscopi-
cally inﬁltrative growth pattern, as determined on whole-
tumour sections, have a considerably higher risk (HR 4.6)
for both local recurrence and metastasis compared to STS
with a pushing growth pattern [8]. The prognostic strength
of inﬁltrative growth was similar to or stronger than that
of other commonly used prognostic factors. The possibil-
ity to identify inﬁltrative growth of STS on MRI has, to our
knowledge, not yet been assessed and we therefore aimed to
evaluate the peripheral tumour growth pattern on preopera-
tive MRI sequences and correlated these ﬁndings to the mi-
croscopical characteristics on whole-tumour sections and to
outcome in 78 patients with STS of the extremities and the
trunk wall.
PATIENTS AND METHODS
Patients
This retrospective investigation was based on adult (> 18
years) patients treated at the Musculoskeletal Tumour Cen-
tre in Lund between 1989 and 2000. Patients with primary
STS of the extremities or the trunk wall who had been re-
ferred to our centre before any surgery and who had no
detectable metastases at the time of diagnosis were eligible
for the study. In addition, preoperative MRI scans should
be available and neoadjuvant chemotherapy or radiotherapy
should not have been administered. In order to compare the2 Sarcoma
Table 1: Clinical pathological characteristics in 78 soft tissue sarco-
mas.
Age
Median (range) years 68 (23–87)
Site
Upper extremity 15
Lower extremity 59
Trunk wall 4
Size
≤ 5cm 23
> 5cm 55
Microscopical diagnosis
Leiomyosarcoma 25
Pleomorphic/unclassiﬁed STS 12
Liposarcoma 12
Myxoﬁbrosarcoma 10
MFH∗ 9
#Other 10
Histological malignancy grade (numbers within
parenthesis refer to patients who developed metastases)
I/II 12 (2)
III 15 (7)
IV 51 (24)
Tumour depth
Subcutaneous 23
Deep-seated 55
Local treatment (numbers within parenthesis refer to
patients who developed local recurrences)
Marginal 9 (2)
Marginal with radiotherapy 24 (5)
Wide∗∗ 45 (6)
∗MFH, malignant ﬁbrous histiocytoma.
#Includes neuroﬁbrosarcoma, MPNST, synovial sarcoma,
extraskeletal chondrosarcoma, and angiosarcoma.
∗∗Radiotherapy administered to two patients.
growth patterns on MRI and on microscopical evaluation,
the tumours should have been resected with a marginal or
a wide surgical margin and whole-tumour sections should
be available. Hereby, we have identiﬁed 78 patients, which
represent a subset of the 140 patients in whom we have pre-
viously reported the prognostic value of microscopical inﬁl-
trative growth on whole-tumour sections [8]. The main rea-
son for exclusion from the former series was that only pre-
operative CT had been performed. The lower extremity was
the most common tumour location, 2/3 of the tumours were
deep-seated, leiomyosarcoma was the commonest histiotype
and 66 of the 78 tumours were high-grade (grades 3 and 4
on a 4-tiered scale) (Table 1). Follow-up was complete for at
least 5 years for the survivors. Local recurrences developed in
13/78 (rate 0.2) patients and metastases in 33/78 (rate 0.4)
patients.
Microscopicassessmentbasedon
whole-tumoursections
This evaluation is a continuation of a previously pub-
lished study [8]. In short, a whole-tumour section was ob-
tained from the maximum tumour diameter and was, af-
t e rd e h y d r a t i o n ,e m b e d d e di n t op a r a ﬃn. The microscopi-
cal assessment was performed on a 4µm slide stained with
haematoxylin-erythrosin. The peripheral tumour growth
pattern was microscopically classiﬁed as pushing in 22 tu-
mours, where no sign of inﬁltrative growth could be de-
tected, or else as inﬁltrative in 56 tumours (inﬁltration
involved < 25% of the tumour rim in 14 tumours and
> 25% in 42 tumours, without diﬀerences in outcome be-
tween these groups, which were subsequently combined)
(see Table 2 and Figure 1). In this subset of 56 tumours,
inﬁltrative growth predicted risk of metastases and lo-
cal recurrence similarly to previously reported [8]w i t h
an HR of 3.7 (95% CI 1.3–11, P = .01) for devel-
opment of metastases and with all local recurrences oc-
curring among inﬁltrative tumours (P = .009; log-rank
test).
AssessmentofpreoperativeMRI
All patients had undergone preoperative MRI, most of them
at local hospitals before referral to our musculoskeletal tu-
mour center. Diﬀerent MRI equipment, including low-Tesla
units as well as 1.5-Tesla units were used. Standard MRI in-
cluded axial and coronal sections, and in some cases also
sagittal sections, with T1- and T2-weighted sequences, coro-
nal STIR sequence, and a static T1-weighted fat saturated
sequence after intravenous contrast medium injection, most
often gadolinium DTPA. The MRI examinations were retro-
spectively evaluated in consensus by two musculoskeletal ra-
diologists (MW and KJ) who were blinded to the histopatho-
logical data and the outcome data. The assessment of pe-
ripheral growth pattern on MRI was based on the largest
midsection of the tumour. Pushing growth pattern was con-
sidered when the tumour was well deﬁned without periph-
eral extension to the surrounding tissue, whereas classiﬁed
as inﬁltrative if the tumour had an irregular surface with
spicula-like extensions into the surrounding tissue. Inﬁltra-
tive growth was classiﬁed as focal (< 25% of the tumour
circumference) or diﬀuse (> 25% of the circumference)
(Figure 1).
Statisticalanalysis
Associations between categorical or categorized variables
were evaluated with chi-squared tests. Time to ﬁrst metasta-
sis and to ﬁrst local recurrence was analyzed using Kaplan-
Meier estimates, log-rank tests, and Cox regression. Pro-
portional hazards assumptions were checked graphically. All
tests were two-sided and the signiﬁcance level was set to .05.
WeusedthestatisticspackageStata9.0(StataCorp2005,Col-
lege Station, Tex).Joseﬁn Fernebro et al 3
Table 2: Correlations between MR ﬁndings and clinicopathological data.
MR classiﬁcation Pushing Focally inﬁltrative Diﬀusely inﬁltrative
Histopathologic growth pattern
Pushing 14 2 met∗,0l r ∗∗ 8 2 met, 0 lr 0 —
Inﬁltrating 20 10 met, 3 lr 17 7 met, 4 lr 19 12 met, 6 lr
Size
≤ 5cm 11 — 8 — 4 —
> 5cm 23 — 17 — 15 —
Depth
Subcutaneous 11 — 5 — 7 —
Deep-seated 23 — 20 — 12 —
Grade
I/II 9 — 3 — 0 —
III 6 — 3 — 6 —
IV 19 — 19 — 13 —
∗met = metastasis.
∗∗lr = local recurrence.
Pushing Inﬁltrating
(a)
Focally inﬁltrating
Focally inﬁltrating
(b)
Figure 1: Examples of MRI scans and whole-tumour sections stained with haematoxylin and erythrosine from 2 diﬀerent leiomyosarcomas;
(a) a subcutaneous tumour of the thigh with a pushing growth pattern on MRI, but microscopic inﬁltration on histopathology, (b) an
intramuscular tumour of the thigh with focally inﬁltrative growth pattern on both MRI and histopathology.
RESULTS
All 22 tumours with a pushing growth pattern on histopa-
thology were classiﬁed as pushing or focally inﬁltrative on
MRI. 4 of these tumours developed metastasis and none
recurred locally. Among the 56 microscopically inﬁltrative
tumours, MRI identiﬁed 37 as pushing or focally inﬁltra-
tive, and 19 as diﬀusely inﬁltrative (Table 2). The MRI-based
growth pattern showed no obvious association with tumour
size, depth, or grade (Table 2); indeed a pushing growth pat-
tern was identiﬁed in 2/3 of the large (> 5cm) tumours and
in 1/3 of the grade IV tumours.
Metastases developed in 12 of the 19 (rate 0.6) diﬀusely
inﬁltrative tumours compared to 21/59 (rate 0.4) in the tu-
mours with a pushing or focally inﬁltrative growth pattern
on MRI (P = .03). The former group had an HR of 2.5
for the risk of development of metastases (95% CI = 1.2–
5.1; P = .01) (Figure 2). Local tumour recurrences devel-
oped in 6/19 (rate 0.3) diﬀusely inﬁltrative tumours com-
pared to 7/59 (rate 0.1) tumours with a pushing or fo-
cally inﬁltrative growth pattern on MRI (P = .04). In the
analysis of local recurrence free survival, inﬁltrative growth
o nM R Is h o w e da nH Ro f3 . 7( 9 5 %C I= 1.2–11; P =
.02).4 Sarcoma
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Figure 2: Kaplan-Meier survival curves in relation to inﬁltrative
growth identiﬁed on MRI (P = .02).
DISCUSSION
MRIhavebecomepartofthestandardprocedureforthepre-
operative evaluation of STS because of high-resolution map-
ping of the anatomical extension of the tumour. Dynamic,
contrast-enhanced MRI has been suggested to diﬀerentiate
viable from nonviable (necrotic or avascular) tumour areas,
and could therefore potentially be valuable for preoperative
prognostication [9]. The overall, prognostic value of preop-
erative MRI, however, is largely unknown. We have in a re-
cent study demonstrated that the microscopical peripheral
tumour growth pattern (pushing versus inﬁltrative) deter-
mined on whole-tumour sections provides new and inde-
pendent prognostic information in STS; tumours with inﬁl-
trative growth have an increased risk for local recurrences as
well as for metastases [8]. We did not analyse the relation be-
tween MRI ﬁndings and prognostic factors such as tumour
size and histologic malignancy grade since our aim was to as-
sess whether growth pattern on MRI could be used for prog-
nosisratherthantoassessavalueofcombiningMRIﬁndings
with other factors in a prognostic system for soft tissue sar-
coma.
In the current study we found that tumours with dif-
fuse inﬁltrative growth on MRI had a worse prognosis, both
with regards to local recurrence and metastasis, whereas tu-
mours with a pushing or focally inﬁltrative growth pattern
on MRI had a better prognosis. In the latter groups MRI
was less accurate; almost one third of the histopathologi-
cally pushing tumours had focal inﬁltration on MRI and
one third of the histopathologically inﬁltrative tumours had
pushing growth on MRI. In our previous study [8] (see
Material and Methods) we found that the percentage of the
tumour rim that was histopathologically inﬁltrative was of
no prognostic importance; tumours were divided into push-
ing tumours, with no inﬁltration anywhere, versus all oth-
ers. In the current study we found the inverse; only diﬀuse
inﬁltration on MRI was of prognostic importance. Diﬃcul-
ties in determining inﬁltration on MRI probably account
for this diﬀerence; the diﬀusely inﬁltrating tumours (with
inﬁltration around the entire tumour rim) are more likely
to identify inﬁltrative growth as determined histopatholog-
ically, whereas focal inﬁltration on MRI may be false posi-
tive.
We recognize several weaknesses in our study, namely,
retrospective analysis and nonstandardized MRI examina-
tions. The resolution was suboptimal in several cases, which
mayreﬂectnonstandardizationaswellasMRIhavingalower
resolution than microscopic examination and this may ex-
plain why inﬁltration was not identiﬁed in many tumours
and classiﬁed as focally inﬁltrative in many tumours with a
pushinggrowthonhistopathology.However,ourﬁndingofa
poor prognosis for tumours with diﬀuse inﬁltration on MRI
suggests that MRI should in a standardized way classify the
peripheral tumour growth pattern. We therefore suggest that
our ﬁndings should be tested in a prospective study using
high-resolution MRI in order to improve the preoperative
risk assessment in patients with STS.
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